Bausch Health Companies Inc. (TSE:BHC – Get Free Report) rose 7.4% on Thursday . The stock traded as high as C$10.40 and last traded at C$9.99. Approximately 63,413 shares changed hands during trading, a decline of 75% from the average daily volume of 252,202 shares. The stock had previously closed at C$9.30.
Bausch Health Companies Stock Up 2.3 %
The firm’s 50 day simple moving average is C$10.56 and its 200-day simple moving average is C$10.35. The company has a current ratio of 1.19, a quick ratio of 0.58 and a debt-to-equity ratio of -1,831.94. The company has a market capitalization of C$2.71 billion, a price-to-earnings ratio of -15.23, a PEG ratio of 0.21 and a beta of 0.77.
About Bausch Health Companies
Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.
Featured Articles
- Five stocks we like better than Bausch Health Companies
- What Are Earnings Reports?
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- How to Effectively Use the MarketBeat Ratings Screener
- DuPont’s Electronics Spinoff: The Start of Something Big
- 3 Fintech Stocks With Good 2021 Prospects
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.
